MX366171B - Composiciones farmaceuticas y metodos terapeuticos de uso que comprenden agonistas selectivos del receptor de melanocortina. - Google Patents

Composiciones farmaceuticas y metodos terapeuticos de uso que comprenden agonistas selectivos del receptor de melanocortina.

Info

Publication number
MX366171B
MX366171B MX2015006333A MX2015006333A MX366171B MX 366171 B MX366171 B MX 366171B MX 2015006333 A MX2015006333 A MX 2015006333A MX 2015006333 A MX2015006333 A MX 2015006333A MX 366171 B MX366171 B MX 366171B
Authority
MX
Mexico
Prior art keywords
pharmaceutical compositions
melanocortin
receptor
selective agonists
formula
Prior art date
Application number
MX2015006333A
Other languages
English (en)
Other versions
MX2015006333A (es
Inventor
A Abdel-Malek Zalfa
Koikov Leonid
J Knittel James
Original Assignee
Univ Cincinnati
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Cincinnati filed Critical Univ Cincinnati
Publication of MX2015006333A publication Critical patent/MX2015006333A/es
Publication of MX366171B publication Critical patent/MX366171B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a los tri- y tetrapéptidos cortos de acuerdo con la siguiente Fórmula I Ar (CH2) mX1-X2-CO-X3-X4-X5-(Trp) n-NX6R son agonistas, selectivos, potentes del receptor de melanocortina 1 (MC1R). Se proporcionan en la presente composiciones farmacéuticas que incluyen los agonistas de péptido de la Fórmula I de MC1R y métodos para tratar enfermedades de la piel.
MX2015006333A 2012-11-21 2013-11-20 Composiciones farmaceuticas y metodos terapeuticos de uso que comprenden agonistas selectivos del receptor de melanocortina. MX366171B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261729018P 2012-11-21 2012-11-21
PCT/US2013/071033 WO2014081846A2 (en) 2012-11-21 2013-11-20 Pharmaceutical compositions and therapeutic methods of use comprising selective agonists of melanocortin 1 receptor

Publications (2)

Publication Number Publication Date
MX2015006333A MX2015006333A (es) 2016-01-20
MX366171B true MX366171B (es) 2019-07-01

Family

ID=50776668

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2015006333A MX366171B (es) 2012-11-21 2013-11-20 Composiciones farmaceuticas y metodos terapeuticos de uso que comprenden agonistas selectivos del receptor de melanocortina.
MX2015006342A MX365620B (es) 2012-11-21 2013-11-20 Composiciones para el cuidado de la piel y metodos que comprenden agonistas selectivos del receptor de melanocortina 1.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2015006342A MX365620B (es) 2012-11-21 2013-11-20 Composiciones para el cuidado de la piel y metodos que comprenden agonistas selectivos del receptor de melanocortina 1.

Country Status (7)

Country Link
US (3) US9434764B2 (es)
EP (2) EP2925340B8 (es)
AU (3) AU2013348044B2 (es)
CA (2) CA2892134C (es)
ES (2) ES2768423T3 (es)
MX (2) MX366171B (es)
WO (2) WO2014081845A2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3297655B1 (en) * 2015-05-18 2020-04-15 Arizona Board of Regents on Behalf of the University of Arizona Enhanced melanoma cancer prevention by novel melanotropins
CN108883048A (zh) 2016-02-04 2018-11-23 阿拉斯廷护肤公司 用于侵入性和非侵入性程序性护肤的组合物和方法
US11591367B2 (en) 2016-10-04 2023-02-28 Dsm Ip Assets B.V. Melanocortin-1-receptor agonists
CN111182914A (zh) 2017-08-03 2020-05-19 阿拉斯廷护肤公司 用于改善皮肤松弛和身体轮廓的组合物和方法
BR112020008175A2 (pt) * 2017-10-30 2020-10-20 Dsm Ip Assets B.V. compostos inovadores
EP3758730B1 (en) * 2018-02-27 2022-11-02 Lipotrue, S.L. Peptides and compositions for use in cosmetics and medicine
WO2020028694A1 (en) 2018-08-02 2020-02-06 ALASTIN Skincare, Inc. Liposomal compositions and methods of use
BR112022025115A2 (pt) * 2020-06-10 2023-02-07 Mitsubishi Tanabe Pharma Corp Agente profilático ou terapêutico para fotodermatose
CN116925182A (zh) * 2022-04-02 2023-10-24 肽鼎生物科技（深圳）有限公司 多肽药物及凝胶制剂的应用
EP4385515A1 (en) * 2022-12-16 2024-06-19 Bella Aurora Labs, S.A. Composition for skin repigmentation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU760257B2 (en) 1998-12-14 2003-05-08 Palatin Technologies, Inc. Metallopeptide combinatorial libraries and applications
US6579968B1 (en) 1999-06-29 2003-06-17 Palatin Technologies, Inc. Compositions and methods for treatment of sexual dysfunction
CA2453515A1 (en) * 2001-07-11 2003-01-23 Palatin Technologies, Inc. Linear and cyclic melanocortin receptor-specific peptides
US7034004B2 (en) * 2002-05-07 2006-04-25 University Of Florida Peptides and methods for the control of obesity
WO2005048967A1 (en) 2003-11-24 2005-06-02 Clinuvel Pharmaceuticals Limited A method of inducing melanogenesis in humans with mc1r variant alleles
JP5449673B2 (ja) 2004-10-08 2014-03-19 クリヌベール、ファーマスーティカルズ、リミテッド 対象者におけるメラニン形成を誘導するための組成物および方法
WO2009047809A2 (en) * 2007-10-12 2009-04-16 Decode Genetics Ehf Sequence variants for inferring human pigmentation patterns
CN102143970B (zh) 2008-05-27 2017-02-08 健赞股份有限公司 α‑促黑素细胞激素的肽类似物
NZ599774A (en) * 2009-11-23 2014-11-28 Palatin Technologies Inc Melanocortin-1 receptor-specific cyclic peptides

Also Published As

Publication number Publication date
MX2015006333A (es) 2016-01-20
AU2013348043A1 (en) 2015-06-04
EP2922565A4 (en) 2016-06-15
US9834580B2 (en) 2017-12-05
EP2925340A4 (en) 2017-01-04
EP2925340B8 (en) 2019-07-24
US9434764B2 (en) 2016-09-06
EP2922565A2 (en) 2015-09-30
ES2768423T3 (es) 2020-06-22
EP2925340B1 (en) 2019-05-08
AU2013348044A1 (en) 2015-06-04
WO2014081845A2 (en) 2014-05-30
CA2892134C (en) 2022-10-04
US10301355B2 (en) 2019-05-28
AU2018204153A1 (en) 2018-06-28
US20150297667A1 (en) 2015-10-22
CA2892134A1 (en) 2014-05-30
WO2014081845A3 (en) 2015-07-30
MX2015006342A (es) 2016-02-25
AU2013348044B2 (en) 2018-03-15
MX365620B (es) 2019-06-07
US20150299251A1 (en) 2015-10-22
CA2892144A1 (en) 2014-05-30
AU2018204153B2 (en) 2019-04-18
CA2892144C (en) 2020-04-28
AU2013348043B2 (en) 2017-11-02
WO2014081846A2 (en) 2014-05-30
ES2738555T3 (es) 2020-01-23
EP2922565B1 (en) 2019-11-13
WO2014081846A3 (en) 2015-11-19
US20180066016A1 (en) 2018-03-08
EP2925340A2 (en) 2015-10-07

Similar Documents

Publication Publication Date Title
MX2015006333A (es) Composiciones farmaceuticas y metodos terapeuticos de uso que comprenden agonistas selectivos del receptor de melanocortina.
AU2018201997B2 (en) Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions
MX2014002668A (es) Tratamiento de enfermedades relacionadas con subunidades alfa de canales de sonido regulados por voltaje (scnxa) con moleculas pequeñas.
TW201129368A (en) Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions
CA2902938C (en) Peptides for skin rejuvenation and methods of using the same
MX337830B (es) Peptidos utiles en el tratamiento y/o cuidado de la piel y/o cabello y su uso en composiciones cosmeticas o farmaceuticas.
PE20190515A1 (es) Peptidos modificados de auristatina y conjugados anticuerpo-farmaco de los mismos
BR112016012538A2 (pt) peptídeos citotóxicos e conjugados dos mesmos
PE20140382A1 (es) Polipeptidos derivados de la il-2 con actividad agonista para la terapia del cancer e infecciones cronicas
IN2012DN06720A (es)
ES2397889A1 (es) PÉPTIDOS MODULADORES DE PGC-1Alfa.
NZ702392A (en) Compositions and methods for cancer immunotherapy
CL2012003604A1 (es) Compuestos heterociclicos derivados de piridina carboxamida sustituida; proceso de preparacion; composicion farmaceutica; combinacion farmaceutica; uso en el tratamiento de trastornos proliferativos celulares, enfermedad de parkinson, cancer, entre otros.
SG10201907684PA (en) Androgen receptor modulator and uses thereof
MX2018006299A (es) Analogos de peptido de la hormona de estimulacion de alfa-melanocito.
CL2015002202A1 (es) Benzamidas sustituidas con actividad hacia receptores ep4.
CL2013003484A1 (es) Compuestos derivados de n-(4-morfolin-2-il)fenil)-1h-pirazol-(3 o 5)-carboxamida o n-(4-piperidin-3-il)fenil)-1h-pirazol-(3 o 5)-carboxamida afines a receptores asociados a taar1; procedimiento de preparacion; composicion farmaceutica y uso en el tratamiento y/o la profilaxis de enfermedades tales como depresion, trastorno bipolar, alzheimer y parkinson, entre otras.
CU20120042A7 (es) (heteroarilmetil)tiohidantoínas sustituidas como drogas anticáncer
MX2019010382A (es) Metodo de tratamiento de tumor inmunoterapeutico utilizando un agonista alfa,beta-selectivo del receptor de interleuquina-2 en combinacion con terapia de transferencia celular adoptiva.
UY33222A (es) Secuencias de aminoácidos dirigidas contra el receptor de superficie celular 2 de TRAIL, compuestos, construcciones y variantes efectivas
MX2018000419A (es) Derivados de amida sustituida que tienen actividad multimodal contra el dolor.
EP3501532A3 (en) Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
MX2016006604A (es) Derivados de piperidina con actividad multimodal contra el dolor.
PH12016500978A1 (en) Piperazine derivatives having multimodal activity against pain
MX2017006437A (es) Compuestos espiroisoquinolin-1,4'-piperidinicos con actividad multimodal contra el dolor.

Legal Events

Date Code Title Description
FG Grant or registration